| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1634594A MAGE-1 and IL-18 co-expression gene vaccine and its construction method |
| 07/06/2005 | CN1634581A Vaccine composition for preventing AIDS |
| 07/06/2005 | CN1634578A Leptospirosis vaccine and its use |
| 07/06/2005 | CN1634569A Animal interferon gene engineering biologically active preparation |
| 07/06/2005 | CN1209464C Synthesis method of poly deoxynucleotides |
| 07/06/2005 | CN1209461C Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 07/06/2005 | CN1209460C No.6 gene segment of rice dwarfing virus |
| 07/06/2005 | CN1209459C Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicing of sample and kinetics of genetoxicity |
| 07/06/2005 | CN1209457C Preparation and selection of donor cells for nuclear transplantation |
| 07/06/2005 | CN1209374C Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 07/06/2005 | CN1209373C Human protein with suppression to cancer cell growth and its coding sequence |
| 07/06/2005 | CN1209372C Human tumor relative gene CT120 in human 17p 13.3 area and coding protein thereof |
| 07/06/2005 | CN1209370C New human protein with cancer inhibiting function and its encoding sequence |
| 07/06/2005 | CN1209369C Cell death inducing protein and its coding sequence and use |
| 07/06/2005 | CN1209165C Method for cell adhesion and wound healing |
| 07/06/2005 | CN1209164C Compositions comprising DNA damaging agents and P53 |
| 07/06/2005 | CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease |
| 07/06/2005 | CA2452131A1 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 07/05/2005 | US6914175 Process for preparing an anti-oxidant |
| 07/05/2005 | US6914172 Soybean cultivar 0088401 |
| 07/05/2005 | US6914137 Adjustment of pH |
| 07/05/2005 | US6914136 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 07/05/2005 | US6914131 Neisserial antigens |
| 07/05/2005 | US6914125 Scramblase 2 |
| 07/05/2005 | US6914124 Tetracycline-regulated transcriptional activator fusion proteins |
| 07/05/2005 | US6914047 Secreted protein HEMAE80 |
| 07/05/2005 | US6914046 Administering human growth hormone having a specific amino acid sequence to cancer patients who are resistant to, or at risk of developing a resistance to a NF-kappa B-activating cytotoxic molecule |
| 07/05/2005 | US6914043 Frozen food products comprising anti-freeze protein (AFP) type III HPLC 12 |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913925 Producing conditionally-immortalized brain tissues for treatment of parkinson's and nervous system disorders |
| 07/05/2005 | US6913923 Virus envelope vector for gene transfer |
| 07/05/2005 | US6913922 Serotype of adenovirus and uses thereof |
| 07/05/2005 | US6913917 Anti-cocaine catalytic antibody |
| 07/05/2005 | US6913916 Elongase genes and uses thereof |
| 07/05/2005 | US6913915 PEG-modified uricase |
| 07/05/2005 | US6913912 Generation of pantothenic acid and/or a salt; obtain microorganisms, ferment and recover pantothenic acid or salt |
| 07/05/2005 | US6913911 Transgenic microbial polyhydroxyalkanoate producers |
| 07/05/2005 | US6913910 Nucleotide sequences coding for the glk-gene |
| 07/05/2005 | US6913909 Nucleotide sequences coding for the thrE gene and process for the enzymatic production of L-threonine using coryneform bacteria |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913905 Regulatory sequences functioning in filamentous fungi |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913891 Comprises myeloid terminal differentiation (MYD) polypeptide for diagnosis and treatment of leukemia and cell proliferative disorders; antisense agents |
| 07/05/2005 | US6913889 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
| 07/05/2005 | US6913886 Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides |
| 07/05/2005 | US6913883 IGF-1 receptor interacting proteins |
| 07/05/2005 | US6913880 Method for determining transcription factor activity and its technical uses |
| 07/05/2005 | US6913879 Concurrent genetic mapping of preferential genomic fragments; neonatal diagnostic screening |
| 07/05/2005 | US6913755 Amino acid substituted DNA sequences for use as vaccines against streptococcus |
| 07/05/2005 | US6913753 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | US6913751 Recombinant avian herpesvirus useful in vaccine production |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | US6913679 Curves and straight portions of separation apparatus |
| 07/05/2005 | CA2283789C Dna polymerases having improved labeled nucleotide incorporation properties |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2165041C Methods and compositions for synthesis of oligosaccharides, and the products formed thereby |
| 07/05/2005 | CA2129663C Biosynthetic binding protein for cancer marker |
| 07/05/2005 | CA2128686C Electrochemical treatment of nucleic acid containing solutions |
| 06/30/2005 | WO2005059562A2 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases |
| 06/30/2005 | WO2005059515A2 Method for treating neurological disorders |
| 06/30/2005 | WO2005059509A2 Biosensors for detecting macromolecules and other analytes |
| 06/30/2005 | WO2005059172A2 Method and nucleic acids for the improved treatment of breast cell proliferative disorders |
| 06/30/2005 | WO2005059159A2 Dna polymerase compositions for quantitative pcr and methods thereof |
| 06/30/2005 | WO2005059157A2 METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs |
| 06/30/2005 | WO2005059156A2 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used |
| 06/30/2005 | WO2005059149A2 Improved protein production |
| 06/30/2005 | WO2005059148A1 Recombinase mediated gene traps |
| 06/30/2005 | WO2005059147A2 Plants having modified growth characteristics and method for making the same |
| 06/30/2005 | WO2005059146A1 Avehicle for plant transformation |
| 06/30/2005 | WO2005059145A1 Method to increase salt tolerance in plants |
| 06/30/2005 | WO2005059144A1 Psod expression units |
| 06/30/2005 | WO2005059143A1 Pgro expression units |
| 06/30/2005 | WO2005059141A1 Method of constructing yellow flower by regulating flavonoid synthesis system |
| 06/30/2005 | WO2005059140A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | WO2005059138A1 Methods and compounds for altering the load of hepatitis virus |
| 06/30/2005 | WO2005059137A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/30/2005 | WO2005059135A2 Treatment of mammals by sirna delivery into mammalian nerve cells |
| 06/30/2005 | WO2005059134A1 COMPOUNDS AND METHODS FOR RNA INTERFERENCE OF THE p65 SUBUNIT OF NF-KAPPA-B |
| 06/30/2005 | WO2005059133A2 Combination therapy associating a tgf-breta antagonist with a chemiotherapeutic agent |
| 06/30/2005 | WO2005059132A1 Rnai potency prediction method |
| 06/30/2005 | WO2005059131A2 Protein binding miniature proteins and uses thereof |
| 06/30/2005 | WO2005059130A1 Arachidonic acid-containing plant and utilization of the same |
| 06/30/2005 | WO2005059129A2 Adapter for coupling a substance which is to be coupled to a cell surface |
| 06/30/2005 | WO2005059125A1 Variants of phosphotriesterases with enhanced and/or altered substrate specificity |
| 06/30/2005 | WO2005059121A2 Dominant gene suppression transgenes and methods of using same |
| 06/30/2005 | WO2005059120A1 Methods of preventing transplantation rejection by creating immunologically neutral stem cells using gene silencing technology |
| 06/30/2005 | WO2005059111A2 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA |
| 06/30/2005 | WO2005059103A2 Corn plant mon88017 and compositions and methods for detection thereof |
| 06/30/2005 | WO2005059102A2 METHOD FOR OBTAINING AN ENRICHED POPULATION OF siRNA-EXPRESSING CELLS |
| 06/30/2005 | WO2005059094A2 Novel methods of inorganic compound discovery and synthesis |
| 06/30/2005 | WO2005059093A2 P ef-tu expression units |
| 06/30/2005 | WO2005058963A1 Anti-hiv antibody |
| 06/30/2005 | WO2005058960A1 Cytochrome c protein and assay |
| 06/30/2005 | WO2005058957A2 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | WO2005058956A1 Cytokine binding domains |
| 06/30/2005 | WO2005058953A2 Ogh fusion polypeptides and therapeutic uses thereof |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |